Shengke Pharmaceuticals (Jiangsu) Limited, China
1 clinical trials · Sponsor
◉ Watch Shengke Pharmaceuticals (Jiangsu) Limited, China
| Record | Firm | Date |
|---|---|---|
| A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients (NCT05758610) | Shengke Pharmaceuticals (Jiangsu) Limited, China | 2022-11-04 |
Track Shengke Pharmaceuticals (Jiangsu) Limited, China automatically
Every clearance here is in the API, with alerts when new ones post.